Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

NCT ID: NCT05812898

Last Updated: 2024-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the aim of the study is to investigate the effect of deep front line myofascial release to selected exercises in patients with knee osteoarthritis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

: Knee osteoarthritis (KOA) also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage.

The myofascial meridian is a new approach to the facial restriction .the knee capsules, the adductor muscles and the tipialis posterior are part of the deep front line which is a line of the myofascial meridian.

Exercise is the highest evidence in the treatment of knee osteoarthritis. The myofascial release is effective in the treatment of knee osteoarthritis so the study will investigate the effect of adding deep front line myofascial release to selected exercises in patients with knee osteoarthritis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

exercise plus myofascial release of the adductor and tipialis posterior muscles.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

The control group received selective exercises therapy in the form of strengthening and stretching exercises for selective muscles of hip and knee

Group Type SHAM_COMPARATOR

exercises

Intervention Type OTHER

strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles

study group

The study group received selective exercises therapy in the form of strengthening and stretching exercises for selective muscles of hip and knee, plus myofascial release technique of the deep front line.

Group Type EXPERIMENTAL

exercises

Intervention Type OTHER

strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles

myofascial release

Intervention Type OTHER

myofascial release using instrument assisted soft tissue mobilization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exercises

strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles

Intervention Type OTHER

myofascial release

myofascial release using instrument assisted soft tissue mobilization

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mild to moderate unilateral or bilateral medial tibiofemoral OA grade II-III (K/L).
* The age of the participants will range from 45 to 60 years old .
* BMI ranged from 20-30 kg/m2

Exclusion Criteria

1. Severe knee OA (grade IV according to K/L classification).
2. Congenital or acquired inflammatory, rheumatic or neurological (systemic or local) diseases involving the knee.
3. Patients receiving oral or injected corticosteroids for the last 3 months .
4. History of knee surgery/fracture.
5. Patients with ACL and meniscus injury
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hoda mohamed Ahmed

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

hoda m Ahmed, bachelor

Role: PRINCIPAL_INVESTIGATOR

phyical therapist at Cairo university hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hoda Mohamed Ahmed

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/004281

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.